261 related articles for article (PubMed ID: 15987289)
1. A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis.
Gupta AK; Leonardi C; Stoltz RR; Pierce PF; Conetta B;
J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):437-43. PubMed ID: 15987289
[TBL] [Abstract][Full Text] [Related]
2. A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis.
Sigurgeirsson B; van Rossem K; Malahias S; Raterink K
J Am Acad Dermatol; 2013 Sep; 69(3):416-25. PubMed ID: 23706639
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of fosravuconazole L-lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study.
Watanabe S; Tsubouchi I; Okubo A
J Dermatol; 2018 Oct; 45(10):1151-1159. PubMed ID: 30156314
[TBL] [Abstract][Full Text] [Related]
4. Efinaconazole solution in the treatment of toenail onychomycosis: a phase 2, multicenter, randomized, double-blind study.
Tschen EH; Bucko AD; Oizumi N; Kawabata H; Olin JT; Pillai R
J Drugs Dermatol; 2013 Feb; 12(2):186-92. PubMed ID: 23377392
[TBL] [Abstract][Full Text] [Related]
5. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
Gupta AK; Konnikov N; Lynde CW
J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
[TBL] [Abstract][Full Text] [Related]
6. A randomized, placebo- and active-controlled, parallel-group, multicentre, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis.
Elewski B; Pollak R; Ashton S; Rich P; Schlessinger J; Tavakkol A
Br J Dermatol; 2012 Feb; 166(2):389-98. PubMed ID: 21967490
[TBL] [Abstract][Full Text] [Related]
7. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
Gupta AK; Lynde CW; Konnikov N
J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
[TBL] [Abstract][Full Text] [Related]
8. Safety, Pharmacokinetics, and Efficacy of Efinaconazole 10% Topical Solution for Onychomycosis Treatment in Pediatric Patients.
Eichenfield LF; Elewski B; Sugarman JL; Rosen T; Vlahovic TC; Gupta AK; Stein Gold L; Pillai R; Guenin E
J Drugs Dermatol; 2020 Sep; 19(9):867-872. PubMed ID: 33026753
[TBL] [Abstract][Full Text] [Related]
9. [Drug properties of fosravuconazole L-lysine ethanolate (NAILIN
Nakano M; Aoki Y; Yamaguchi H
Nihon Yakurigaku Zasshi; 2019; 153(2):79-87. PubMed ID: 30745518
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of three doses of once-weekly fluconazole (150, 300, and 450 mg) in distal subungual onychomycosis of the toenail.
Rich P; Scher RK; Breneman D; Savin RC; Feingold DS; Konnikov N; Shupack JL; Pinnell S; Levine N; Lowe NJ; Aly R; Odom RB; Greer DL; Morman MR; Bucko AD; Tschen EH; Elewski BE; Smith EB; Hilbert J
J Am Acad Dermatol; 1998 Jun; 38(6 Pt 2):S103-9. PubMed ID: 9631992
[TBL] [Abstract][Full Text] [Related]
11. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.
Gupta AK; Fleckman P; Baran R
J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S70-80. PubMed ID: 11051136
[TBL] [Abstract][Full Text] [Related]
12. Once-weekly fluconazole (150, 300, or 450 mg) in the treatment of distal subungual onychomycosis of the toenail.
Scher RK; Breneman D; Rich P; Savin RC; Feingold DS; Konnikov N; Shupack JL; Pinnell S; Levine N; Lowe NJ; Aly R; Odom RB; Greer DL; Morman MR; Bucko AD; Tschen EH; Elewski BE; Smith EB
J Am Acad Dermatol; 1998 Jun; 38(6 Pt 2):S77-86. PubMed ID: 9631989
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, randomized study comparing itraconazole pulse therapy with continuous dosing for the treatment of toe-nail onychomycosis.
Havu V; Brandt H; Heikkilä H; Hollmen A; Oksman R; Rantanen T; Saari S; Stubb S; Turjanmaa K; Piepponen T
Br J Dermatol; 1997 Feb; 136(2):230-4. PubMed ID: 9068738
[TBL] [Abstract][Full Text] [Related]
14. Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies.
Elewski BE; Rich P; Pollak R; Pariser DM; Watanabe S; Senda H; Ieda C; Smith K; Pillai R; Ramakrishna T; Olin JT
J Am Acad Dermatol; 2013 Apr; 68(4):600-608. PubMed ID: 23177180
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: A randomized, multicenter, double-blind, vehicle-controlled phase 3 study.
Gupta AK; Surprenant MS; Kempers SE; Pariser DM; Rensfeldt K; Tavakkol A
J Am Acad Dermatol; 2021 Jul; 85(1):95-104. PubMed ID: 32585278
[TBL] [Abstract][Full Text] [Related]
16. Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail.
Lipner SR; Scher RK
Expert Rev Clin Pharmacol; 2015; 8(6):719-31. PubMed ID: 26325488
[TBL] [Abstract][Full Text] [Related]
17. Management of toenail onychomycosis with 2% butenafine and 20% urea cream: a placebo-controlled, double-blind study.
Syed TA; Ahmadpour OA; Ahmad SA; Shamsi S
J Dermatol; 1998 Oct; 25(10):648-52. PubMed ID: 9830263
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study.
Watanabe S; Kishida H; Okubo A
J Dermatol; 2017 Jul; 44(7):753-759. PubMed ID: 28332720
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Factors for Complete Cure Following Treatment of Mild and Moderate Toenail Onychomycosis With Efinaconazole Topical Solution 10.
Jellinek NJ; Korotzer A
J Drugs Dermatol; 2015 Aug; 14(8):871-5. PubMed ID: 26267732
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of continuous and pulse dose terbinafine regimes in toenail dermatophytosis: A randomized double-blind trial.
Yadav P; Singal A; Pandhi D; Das S
Indian J Dermatol Venereol Leprol; 2015; 81(4):363-9. PubMed ID: 26087080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
